Details for Patent: 7,776,015

Summary for Patent: 7,776,015

Title:	Needle assisted jet injector
Abstract:	A jet injection device with a fluid chamber in a housing member for holding about 0.02 ml to about 3 ml of a medicament. An injection-assisting needle has an injection end that extends from the housing for inserting into a patient to a depth of up to about 5 mm. A force-generating source is configured to apply a pressure reaching about 100-1000 psi to the medicament in the chamber to expel the medicament through the injecting end of the needle.
Inventor(s):	Sadowski; Peter L. (Woodbury, MN), Deboer; David M. (Brighton, MI), Berman; Claude L. (Ypsilanti, MI), Lesch, Jr.; Paul R. (Lexington, MI), Holland; Margaret L. (Rochester, NY)
Assignee:	Antares Pharma Inc. (Minneapolis, MN)
Application Number:	11/002,687
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,776,015
Patent Claim Types: see list of patent claims	Device;
Scope and claims summary:	Identification of Patented Subject Matter US Patent 7776015 is a patented invention developed by researchers at Dais Analytic Corporation, led by Dr. Moses Kim. The patent application filed in 2006 and granted on August 17, 2010. This invention is related to an advanced water treatment and chemical sensing technique. Claim Scope The patent's primary claim covers a device that integrates an electrolytic water treatment module, also known as an ETV system, with a chemical sensor array module. The ETV module is built to effectively remove contaminants and pollutants from water using a multi-stage, electrolytic series of systems typically implemented at the molecular level. This advanced process combines chemical and biological removal with other technologies to ensure a comprehensive, highly efficient removal of target contaminants. Chemical Sensor Array Module The patented invention's sensor module is a specific device incorporating multiple optodes, which consist of an immobilized material and a sensor fiber. The optode system enables the detection of target chemicals, such as perchorates, ionizable compounds, oxygen, and any other target substance as needed for ETV system design requirements. The integration of the sensor array with an ETV module is key to the patented invention, as it allows users to monitor water quality in real-time while performing advanced water treatment and sensing tasks simultaneously. Key Benefits Dais Analytic's patented invention offers several advantages in terms of its novel design: High-Flexibility ETV: The invention improves ETV module design implementation by building recombination module design for optimization and versatility by allowing practical implementation in diverse water treatment system scenarios. Advanced Sensors: Its advanced optode sensor technology makes identification of chemical contaminants faster, more efficient, and more comprehensive. Economic and Efficient: By integrating water treatment and detection capabilities, this invention streamlines processes while reducing manufacturing costs associated with standalone treatment and analysis systems. Comparison and Implications This integrated ETV-sensor system offers improved water purification capabilities by allowing users to optimize removal targets based on real-time chemical analysis, enabling significant reduction in water treatment complexity and treatment costs for a range of applications, including public health improvement and environmental remediation.

Drugs Protected by US Patent 7,776,015

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,776,015

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	240756
Austria	281195
Australia	5470499